Real-world observation of the efficacy and prognostic factors analysis of apatinib for patients with advanced gastric cancer.
2020
e15508Background: Apatinib is the first oral anti-angiogenic agent approved for the treatment of advanced gastric cancer in China. With the development of marketing promotion, the real world observ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI